Yarrow Bioscience Logo (full size)
Yarrow Bioscience Logo icon/symbol
Yarrow Bioscience Logo (full size) on a dark background
Yarrow Bioscience Logo icon/symbol on a dark background
About Yarrow Bioscience
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.
October 5th, 2026
